ALPHA2C adrenoreceptor agonists
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 26, 2011
Grant Date -
Jul 8, 2010
app pub date -
Mar 12, 2010
filing date -
Aug 25, 2005
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
In its many embodiments, the present invention relates to a novel class of phenylmorpholine and phenylthiomorpholine compounds useful as α2C adrenergic receptor agonists, pharmaceutical compositions containing the compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the α2C adrenergic receptor agonists using such compounds or pharmaceutical compositions.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully